Gardasil For Males Gets FDA OK; Next Up, Cost-Effectiveness Questions

Merck's Gardasil human papillomavirus vaccine is headed back for a key review by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices on Oct. 21 with FDA's safety and efficacy approval in hand